Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Drug Policy
Related: About this forumDEA announces: Increase in marijuana produced by govt. for research
http://norml.org/news/2014/05/08/federal-government-to-increase-its-supply-of-marijuana-for-clinical-research
Last week, the US Drug Enforcement Administration (DEA) announced in the Federal Register that it is increasing its marijuana production quota from 21 kilograms to 650 kilograms (about 1,443 pounds) in order to meet increasing demand for the plant from clinical investigators.
Federal regulations permit a farm at the University of Mississippi to cultivate set quantities of cannabis for use in federally approved clinical trials. Regulators at the DEA, the US Food and Drug Administration, PHS (Public Health Service), and the US National Institute on Drug Abuse must approve any clinical protocol seeking to study the plant's effects in human subjects.
On various occasions, marijuana reform advocates and researchers have publicly criticized NIDA for focusing on protocols designed to find harms associated with marijuana while simultaneously stonewalling proposed trials seeking to assess the plant's therapeutic benefits. However, in March, federal regulators finally signed off on a long-delayed clinical protocol from researchers at the University of Arizona College of Medicine to evaluate the use of cannabis in war veterans suffering from post-traumatic stress. Also this spring, lawmakers in several states, including Alabama, Kentucky, and Wisconsin, passed legislation encouraging state-sponsored clinical trials to assess the therapeutic potential of cannabidiol - a nonpsychotropic organic component of cannabis - in the treatment of intractable epilepsy.
"The additional supply [of cannabis] to be manufactured in 2014 is designed to meet the current and anticipated research efforts involving marijuana," a NIDA spokesperson told TheHill.com. "[T]his projection of increased demand is due in part to the recent increased interest in the possible therapeutic uses of marijuana."
Last week, the US Drug Enforcement Administration (DEA) announced in the Federal Register that it is increasing its marijuana production quota from 21 kilograms to 650 kilograms (about 1,443 pounds) in order to meet increasing demand for the plant from clinical investigators.
Federal regulations permit a farm at the University of Mississippi to cultivate set quantities of cannabis for use in federally approved clinical trials. Regulators at the DEA, the US Food and Drug Administration, PHS (Public Health Service), and the US National Institute on Drug Abuse must approve any clinical protocol seeking to study the plant's effects in human subjects.
On various occasions, marijuana reform advocates and researchers have publicly criticized NIDA for focusing on protocols designed to find harms associated with marijuana while simultaneously stonewalling proposed trials seeking to assess the plant's therapeutic benefits. However, in March, federal regulators finally signed off on a long-delayed clinical protocol from researchers at the University of Arizona College of Medicine to evaluate the use of cannabis in war veterans suffering from post-traumatic stress. Also this spring, lawmakers in several states, including Alabama, Kentucky, and Wisconsin, passed legislation encouraging state-sponsored clinical trials to assess the therapeutic potential of cannabidiol - a nonpsychotropic organic component of cannabis - in the treatment of intractable epilepsy.
"The additional supply [of cannabis] to be manufactured in 2014 is designed to meet the current and anticipated research efforts involving marijuana," a NIDA spokesperson told TheHill.com. "[T]his projection of increased demand is due in part to the recent increased interest in the possible therapeutic uses of marijuana."
Feeling the heat of public disgust, perhaps?
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
4 replies, 1916 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (1)
ReplyReply to this post
4 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
DEA announces: Increase in marijuana produced by govt. for research (Original Post)
RainDog
May 2014
OP
Mnemosyne
(21,363 posts)1. It's a start. Wonder how much research went into liquor/beer? I'm up for these clinical trials. nt
RainDog
(28,784 posts)2. This is related to medical marijuana, not recreational
Cause, you know, marijuana hasn't been studied for forever already, so, yes! More tests!
...actually - this issue is separate from the recreational issue - so I am glad to see the NIDA/DEA is addressing this issue.
Scientists have complained about it - said it's like letting creationists control paleontology research.
There ARE dinosaurs involved in this issue - but they're in bureaucracies, not in the ground.
Mnemosyne
(21,363 posts)4. I know, such a mysterious substance.
I wonder why they don't just pull out Nixon's marijuana study and stop the crap.
intaglio
(8,170 posts)3. You could have a lot of fun trolling Birther sites
claiming this excess was for the President's personal use.